ARTICLE | Clinical News
Alexion Pharmaceuticals preclinical data
April 3, 1995 7:00 AM UTC
The New Haven, Conn., company presented preclinical findings showing that its packaging cell lines produce retroviral particles deficient in alphaGal, the carbohydrate epitope that signals complement activation when bound to antibodies. ...